Consensus Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
33.19 ^USD	+5.84%		+0.15%	+7.83%

Jun. 07	Jefferies Upgrades Collegium Pharmaceutical to Buy From Hold, Adjusts Price Target to $44 From $41	MT
Jun. 05	Collegium Pharmaceutical Insider Sold Shares Worth $814,180, According to a Recent SEC Filing	MT

Evolution of the average Target Price on Collegium Pharmaceutical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1d8.whboViAeJzMGvE70nGarJU-F6bKuIu0ynDS_KZszZt8.lUS9FVd5RlhMz3mQrVOaTgzCr8HbTbVTzXjTbsJGI-aHZZpmF2pSYHz5Bw~e9462d64181fc846912c71509deb16e4

Analyst Recommendations on Collegium Pharmaceutical, Inc.

Jefferies Upgrades Collegium Pharmaceutical to Buy From Hold, Adjusts Price Target to $44 From $41	Jun. 07	MT
Collegium Pharmaceutical Insider Sold Shares Worth $814,180, According to a Recent SEC Filing	Jun. 05	MT
Needham Downgrades Collegium Pharmaceutical to Hold From Buy	May. 10	MT
Piper Downgrades Collegium Pharmaceutical to Neutral From Overweight, Price Target at $39	May. 10	MT
Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating	Feb. 26	MT
Truist Adjusts Price Target on Collegium Pharmaceutical to $40 From $37, Maintains Buy Rating	Feb. 26	MT
Truist Adjusts Collegium Pharmaceutical's Price Target to $37 From $31, Keeps Buy Rating	Jan. 04	MT
Jefferies Downgrades Collegium Pharmaceutical to Hold From Buy, Raises Price Target to $37 From $30	Jan. 04	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $36 From $35, Maintains Buy Rating	23-08-25	MT
Jefferies Assumes Collegium Pharmaceutical at Buy With $30 Price Target	23-05-02	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $35 From $34, Maintains Buy Rating	23-01-05	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $34 From $36, Maintains Buy Rating	22-11-04	MT
HC Wainwright Downgrades Collegium Pharmaceutical to Neutral From Buy	22-08-08	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $36 From $34, Keeps Buy Rating	22-04-06	MT
Piper Sandler Adjusts Collegium Pharmaceutical's Price Target to $42 From $36, Reiterates Overweight Rating	22-02-22	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $34 From $28, Reiterates Buy Rating	22-02-15	MT
HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 From $26, Reiterates Buy Rating	22-02-15	MT
Cantor Fitzgerald Upgrades Collegium Pharmaceutical to Overweight From Neutral; Price Target is $26	22-02-15	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $28 from $26, Keeps Buy Rating	21-11-15	MT
HC Wainwright Adjusts Collegium Pharmaceutical PT to $26 From $28, Maintains Buy Rating	21-11-05	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $26 From $32, Maintains Buy Rating	21-11-05	MT
COLLEGIUM PHARMACEUTICAL : Cantor Fitzgerald Downgrades Collegium Pharmaceutical to Neutral from Overweight, Adjusts Price Target to $22 from $30	21-08-06	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $28 From $33, Maintains Buy Rating	21-08-06	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 from $31, Maintains Buy Rating	20-11-09	MT